9 to 14 -year -old children's HPV vaccination rate Low in vaccination rate Experts: Hurry up vaccine

The Guangdong Province Cervical Cancer Prevention and Control Strategy Symposium hosted by the Guangdong Provincial Association of Prevention Medicine held a picture of the Guangdong Provincial Prevention Medicine Association in Guangzhou

China News Network, Guangzhou, August 7 (Cai Minjie He Yuhang) "Due to the lack of cognitive HPV diseases and long -term insufficient HPV vaccine, the vaccination rate of HPV vaccines in my country is extremely low. The rate is even less than 1%. "Wu Shengming, president of the Guangdong Provincial Association of Prevention Medicine, said at the Guangdong Province Cervical Cancer Prevention and Control Strategy Seminar on the 6th that it is worthwhile that in recent years, the public's attention to the prevention and control of cervical cancer prevention and control The degree of continuous improvement and the acceleration of the research and development process of local vaccines, domestic HPV vaccines have been listed one after another.

The scientific name of HPV is "Human Polympida Virus", and 99.7%of cervical cancer is infected by HPV. Cervical cancer is the main "killer" recognized by women's health in the world. It ranks fourth in the global women's cancer incidence and female cancer mortality in 2020. It is the only cancer that is clear and anti -controllable.

As a first -level prevention method for cervical cancer, HPV vaccine has been promoted and used in many countries around the world. Wu Shengming said that as of April 25, 2022, 111 countries/regions have been vaccinated into the national immunization plan. The HPV vaccine needs to be vaccinated before sexual behavior. The earlier, the better the vaccine. Inoculation of HPV vaccine is the most effective and economic means to prevent cervical cancer. It is recommended that girls from 9 to 14 years old act as the primary vaccination targets to give priority to ensuring the high vaccination rate of the crowd.

Yu Wenzhou, chief physician of the China Disease Prevention and Control Center, said that the highest HPV type in the country and even the world's highest infection rate is 16/18, and the cancer in HPV infection, of which 70.8%of the cervical cancer is caused by HPV16/18. The World Health Organization's position states that from the perspective of public health, the prevention of two -valent, four -valent, and nine -valent vaccines has considerable immunogenicity and effectiveness in the prevention of cervical cancer caused by type 16 and 18 HPVs.

According to the study of Chinese women's cervical cancer epidemonicism, there are two peak periods for high -risk HPV infections. The first peak period is 15 to 24 years old, and the second peak period is 40 to 44 years old. The main cause of cancer.

"What we are most worried about is not vaccination, and we never do screening. Clinically, I have been diagnosed with many patients with HPV infection in their twenties to thirty. Diseases are even cervical cancer. I have only 18 years old patients with the youngest cervical cancer. "Qian Deying, director of the obstetrics and gynecology department of the People's Hospital of Guangdong Province, said," These patients in their twenties are inocular 10 years ago. After the vaccine, there will be no today, so I call on everyone to act quickly. "

钱德英还指出，如果15岁之前接种疫苗只需要接种两针，而且如果15岁之前已经接种过HPV疫苗的女性，在25岁后每5年做一次宫颈癌的筛查即可，但是如果Without vaccination, it takes 2 to 3 years to screen.

"When a woman gets a positive HPV -positive list, the first thing to do is to check the cell scraper. If the cell scraping tablet is also a problem, the second step is the clear diagnosis of the vulvation mirror." Qian Deying said.

Recently, my country's latest dual -price HPV vaccine has been listed. According to Yang Hongwei, director of the Marketing Department of Watson Biomedicine, the immunization of the vaccine adapts to women aged 9 to 30. Clinical trials show that women 9 to 17 are immune for 42 months. Keeping above 97%, this shows that after vaccination HPV vaccine can provide long -term protection for women.

Li Xiaomao, a professor of obstetrics and gynecology at the Third Hospital of Sun Yat -sen University, pointed out that the launch of this new HPV vaccine will effectively alleviate the shortage of shortage of HPV vaccine supply, which has added a new choice for the majority of women to prevent cervical cancer.

- END -